Patents by Inventor Ayako Asai

Ayako Asai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition for prevention and treatment of amyotrophic lateral sclerosis
    Patent number: 9856210
    Abstract: The present invention provides a prophylactic or therapeutic agent for amyotrophic lateral sclerosis, containing a 1,3-diphenylurea derivative or multikinase inhibitor.
    Type: Grant
    Filed: September 2, 2011
    Date of Patent: January 2, 2018
    Assignee: Kyoto University
    Inventors: Haruhisa Inoue, Shiho Kitaoka, Kayoko Tsukita, Ryosuke Takahashi, Gaku Murakami, Norio Nakatsuji, Motonari Uesugi, Yasuyuki Asai, Ayako Asai, Yuji Amagai, Kazuhiro Aiba
  • Method for producing hematopoietic stem cells using pyrazole compounds
    Patent number: 9212348
    Abstract: An expanding agent for hematopoietic stem cells and/or hematopoietic progenitor cells useful as a therapy for various hematopoietic diseases and useful for improvement in the efficiency of gene transfer into hematopoietic stem cells for gene therapy is provided. A method of producing hematopoietic stem cells and/or hematopoietic progenitor cells, which comprises expanding hematopoietic stem cells by culturing hematopoietic stem cells ex vivo in the presence of a compound represented by the formula following (I), a tautomer or pharmaceutically acceptable salt of the compound or a solvate thereof (wherein R1 to R8 are as defined in the description).
    Type: Grant
    Filed: December 1, 2011
    Date of Patent: December 15, 2015
    Assignees: NISSAN CHEMICAL INDUSTRIES, LTD., REPROCELL INCORPORATED
    Inventors: Taito Nishino, Makiko Yui, Yasuyuki Asai, Ayako Asai
  • METHOD FOR PRODUCING HEMATOPOIETIC STEM CELLS USING PYRAZOLE COMPOUNDS
    Publication number: 20140057353
    Abstract: An expanding agent for hematopoietic stem cells and/or hematopoietic progenitor cells useful as a therapy for various hematopoietic diseases and useful for improvement in the efficiency of gene transfer into hematopoietic stem cells for gene therapy is provided. A method of producing hematopoietic stem cells and/or hematopoietic progenitor cells, which comprises expanding hematopoietic stem cells by culturing hematopoietic stem cells ex vivo in the presence of a compound represented by the formula following (I), a tautomer or pharmaceutically acceptable salt of the compound or a solvate thereof (wherein R1 to R8 are as defined in the description).
    Type: Application
    Filed: December 1, 2011
    Publication date: February 27, 2014
    Applicants: REPROCELL INCORPORATED, NISSAN CHEMICAL INDUSTRIES, LTD.
    Inventors: Ayako Asai, Taito Nishino, Makiko Yui
  • PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS
    Publication number: 20130225642
    Abstract: The present invention provides a prophylactic or therapeutic agent for amyotrophic lateral sclerosis, containing a 1,3-diphenylurea derivative or multikinase inhibitor.
    Type: Application
    Filed: September 2, 2011
    Publication date: August 29, 2013
    Applicant: KYOTO UNIVERSITY
    Inventor: Ayako Asai